H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 94 Citations 30,026 255 World Ranking 136 National Ranking 67
Medicine D-index 86 Citations 25,714 233 World Ranking 7117 National Ranking 3909

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Fungus

Michael G. Rinaldi mostly deals with Microbiology, Fluconazole, Mycosis, Amphotericin B and Itraconazole. His study in Voriconazole, Minimum inhibitory concentration, Broth microdilution, Posaconazole and Aspergillus is done as part of Microbiology. The concepts of his Fluconazole study are interwoven with issues in Azole and Candida albicans.

His Mycosis research includes themes of Pathology, Internal medicine, In vitro and Virology. His Amphotericin B study combines topics in areas such as Trichosporon beigelii, Chromatography, Fungi imperfecti and Aspergillus terreus. His studies deal with areas such as Antibiotics, Etest, Pseudallescheria boydii, Ketoconazole and Pharmacology as well as Itraconazole.

His most cited work include:

  • Transcatheter Mitral-Valve Repair in Patients with Heart Failure (884 citations)
  • Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole (831 citations)
  • RESISTANCE OF CANDIDA SPECIES TO FLUCONAZOLE (787 citations)

What are the main themes of his work throughout his whole career to date?

Michael G. Rinaldi mainly focuses on Microbiology, Mycosis, Fluconazole, Amphotericin B and Internal medicine. His biological study spans a wide range of topics, including Dermatology, Pathology, Phaeohyphomycosis and Chemotherapy. His work deals with themes such as Viral disease, Candida glabrata, Candida albicans and Virology, which intersect with Fluconazole.

His Amphotericin B study incorporates themes from Aspergillus fumigatus, Itraconazole, Antibiotics and Aspergillosis. His work focuses on many connections between Itraconazole and other disciplines, such as Pharmacology, that overlap with his field of interest in In vivo and In vitro. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery and Cardiology.

He most often published in these fields:

  • Microbiology (52.34%)
  • Mycosis (36.72%)
  • Fluconazole (34.64%)

What were the highlights of his more recent work (between 2007-2021)?

  • Internal medicine (21.87%)
  • Cardiology (7.81%)
  • Microbiology (52.34%)

In recent papers he was focusing on the following fields of study:

Michael G. Rinaldi mainly investigates Internal medicine, Cardiology, Microbiology, Platelet reactivity and Mitral regurgitation. The Internal medicine study combines topics in areas such as Gastroenterology and Drug. His work is connected to Posaconazole, Broth microdilution, Voriconazole, Amphotericin B and Caspofungin, as a part of Microbiology.

His Posaconazole study combines topics from a wide range of disciplines, such as In vitro and Pharmacology. His Voriconazole research is multidisciplinary, incorporating elements of Itraconazole and Aspergillosis. Amphotericin B and Immunology are commonly linked in his work.

Between 2007 and 2021, his most popular works were:

  • Transcatheter Mitral-Valve Repair in Patients with Heart Failure (884 citations)
  • Infections Caused by Scedosporium spp. (498 citations)
  • MOLECULAR PHYLOGENETIC DIVERSITY, MULTILOCUS HAPLOTYPE NOMENCLATURE, AND IN VITRO ANTIFUNGAL RESISTANCE WITHIN THE FUSARIUM SOLANI SPECIES COMPLEX (290 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Fungus

His primary areas of study are Microbiology, Posaconazole, Internal transcribed spacer, Genetics and Fungi imperfecti. In his research on the topic of Microbiology, Mucor velutinosus is strongly related with Mucorales. The various areas that Michael G. Rinaldi examines in his Posaconazole study include In vitro, Aspergillosis, Pharmacology and Virology.

His studies in Voriconazole integrate themes in fields like Flucytosine, Itraconazole, Drug resistance and Candida krusei. His Drug resistance research is multidisciplinary, relying on both Aspergillus, Aspergillus fumigatus, Minimum inhibitory concentration, Mycosis and Candida spp. His research integrates issues of Trichosporon mycotoxinivorans, Pneumonia, Cystic fibrosis, Pathology and Sputum in his study of Amphotericin B.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

John H. Rex;Michael A. Pfaller;John N. Galgiani;Marilyn S. Bartlett.
Clinical Infectious Diseases (1997)

1225 Citations

Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

John R. Wingard;William G. Merz;Michael G. Rinaldi;Thomas R. Johnson.
The New England Journal of Medicine (1991)

1145 Citations

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Gregg W. Stone;JoAnn Lindenfeld;William T. Abraham;Saibal Kar.
The New England Journal of Medicine (2018)

1136 Citations

RESISTANCE OF CANDIDA SPECIES TO FLUCONAZOLE

J H Rex;M G Rinaldi;M A Pfaller.
Antimicrobial Agents and Chemotherapy (1995)

1127 Citations

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes

Thomas F. Patterson;William R. Kirkpatrick;Mary White;John W. Hiemenz.
Medicine (2000)

979 Citations

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

M. Hong Nguyen;James E. Peacock;Arthur J. Morris;David C. Tanner.
The American Journal of Medicine (1996)

955 Citations

Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

Henry M. Blumberg;Henry M. Blumberg;William R. Jarvis;J. Michael Soucie;Jack E. Edwards.
Clinical Infectious Diseases (2001)

827 Citations

Risk factors for candidemia in neonatal intensive care unit patients

L Saiman;E Ludington;M Pfaller;S Rangel-Frausto.
Pediatric Infectious Disease Journal (2000)

700 Citations

Infections Caused by Scedosporium spp.

Karoll J. Cortez;Emmanuel Roilides;Flavio Quiroz-Telles;Joseph Meletiadis.
Clinical Microbiology Reviews (2008)

630 Citations

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

John H. Rex;Michael A. Pfaller;Thomas J. Walsh;Vishnu Chaturvedi.
Clinical Microbiology Reviews (2001)

601 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael G. Rinaldi

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 257

Josep Guarro

Josep Guarro

Rovira i Virgili University

Publications: 190

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 150

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 137

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 131

Shawn A. Messer

Shawn A. Messer

JMI Laboratories

Publications: 123

Deanna A. Sutton

Deanna A. Sutton

The University of Texas Health Science Center at San Antonio

Publications: 118

Thomas F. Patterson

Thomas F. Patterson

The University of Texas Health Science Center at San Antonio

Publications: 111

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 110

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 110

David W. Denning

David W. Denning

University of Manchester

Publications: 108

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 107

John R. Perfect

John R. Perfect

Duke University

Publications: 106

Daniel J. Diekema

Daniel J. Diekema

University of Iowa Hospitals and Clinics

Publications: 103

David A. Stevens

David A. Stevens

Stanford University

Publications: 100

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 94

Something went wrong. Please try again later.